Skip to main content

成果、报告和出版物

Latest Results

Clariant delivers strong profitability on flat local currency sales in Q2 2025

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

  • Q2 2025 sales of CHF 968 million were flat in local currencies1, as growth in Catalysts and Adsorbents & Additives offset a slight decline in Care Chemicals; stable pricing
  • Q2 2025 EBITDA margin before exceptional items increased by 200 basis points to 17.5 % from 15.5 % in Q2 2024, driven by improvements in Catalysts and Adsorbents & Additives, while flat in Care Chemicals; reported EBITDA margin impacted by CHF 22 million restructuring charges
  • H1 2025 sales increased by 1 % in local currencies1 to CHF 1.981 billion, as growth in Care Chemicals and Adsorbents & Additives offset slightly lower Catalysts sales; pricing was up 1 %
  • H1 2025 EBITDA margin before exceptional items increased by 130 basis points to 18.1 % from 16.8 % in the prior year, driven by improvements in all business units
  • H1 2025 operating cash flow of CHF 116 million, with free cash flow conversion (LTM) of 37 %
  • Investor Day savings program of CHF 80 million well underway with CHF 12 million savings in H1 2025
  • Outlook 2025: 17 – 18 % EBITDA margin before exceptional items confirmed, with local currency sales growth lowered to 1 – 3 %; medium-term targets confirmed 

“We delivered strong profitability in the second quarter of 2025, demonstrating resilience amidst a challenging environment for our sector. Notably, Catalysts returned to growth, with volumes increasing by 5 % compared to the previous year. This strong performance in Catalysts, along with Adsorbents & Additives, was the main driver of the 200-basis point improvement in our EBITDA margin before exceptional items, which was further supported by the successful execution of our savings program,” said Conrad Keijzer, Chief Executive Officer of Clariant. “While we remain focused on driving profitable organic growth, we have revised our 2025 sales guidance to a range of 1 – 3 % growth in local currency, reflecting the continued uncertainty in our end markets. At the same time, we confirm our full-year profitability guidance of 17 – 18 % EBITDA margin before exceptional items, underscoring our confidence in in our ability to sustain improved levels of profitability. Despite ongoing market challenges and macroeconomic uncertainties, we remain fully committed to delivering our medium-term targets, supported by the continued execution of our targeted initiatives,” Conrad Keijzer added.

1 All references to local currency growth, pricing, volumes, and scope exclude the impact from hyperinflation countries Argentina and Türkiye. All references to currency include a net impact from hyperinflation countries Argentina and Türkiye.

Read more  

Results Center

Please use the Results Center to find Clariant’s financial results and associated documents as published in the last five years

  Q1  Q2  Q3  Q4 
Date  29 April 2025 31 July 2025 30 October 2025 26 February 2026
Quiet Period as of  10 April  as of 9 July    
Media Release  EN  EN    
Analyst Presentation EN  EN    
Webcast    Replay    
Audio recording MP3  MP3    
Transcript  EN      
Financial Review / HY Report    EN - XLS    
Annual Report        

  Q1  Q2  Q3  Q4 
Date  30 April 2024 30 July 2024 29 October 2024  28 February 2025
Quiet Period as of  11 April as of 10 July   as of 9 October    as of 10 January 2025
Media Release  EN EN EN  EN
Analyst Presentation EN EN EN  EN
Webcast        
Audio recording MP3 MP3 MP3  MP3
Transcript  EN EN EN  EN
Financial Review / HY Report   EN - XLS    EN - XLS
Annual Report        EN

  Q1  Q2  Q3  Q4 
Date  5 May 2023  28 July 2023  30 October 2023  29 February 2024 
Quiet Period as of  17 April as of 10 July as of 10 October as of 15 January 
Media Release  EN — DE  EN — DE EN — DE  EN — DE
Analyst Presentation  EN  EN EN  EN
Webcast        
Audio recording MP3  MP3  MP3  MP3
Transcript  EN  EN EN EN 
Financial Review / HY Report   EN   EN — XLS
Annual Report       EN 

  Q1  Q2  Q3  Q4 
Date  15 June 2022  28 July 2022  27 October 2022  2 March 2023 
Quiet Period   as of 11 July  as of 10 October  as of 17 February 
Media Release  EN — DE EN — DE  EN — DE  EN — DE 
Analyst Presentation  EN  EN  EN  EN 
Webcast        
Audio recording MP3  MP3  MP3  MP3 
Transcript 
    EN 
Financial Review / HY Report   EN    EN 
Annual Report       EN 

  Q1  Q2  Q3  Q4 
Date  29 April 2021  29 July 2021  28 October 2021  19 May 2022 
Quiet Period as of 19 April  as of 12 July  as of 18 October   
Media Release  EN — DE EN — DE  EN — DE  EN — DE 
Analyst Presentation  EN  EN  EN  EN 
Webcast        
Audio recording MP3  MP3  MP3  MP3 
Transcript       
Financial Review / HY Report   EN    EN 
Annual Report        EN  

Conferences and Roadshows

Clariant's Management and Investor Relations Team regularly participates in Conferences and Roadshows. Below you can find an overview of the presentations provided at such events in the last two years. 

For an overview of upcoming events, please refer to the Financial Calendar.

页面摘要

摘要生成中